Mimura Yoshihisa, Yasujima Tomoya, Ohta Kinya, Inoue Katsuhisa, Yuasa Hiroaki
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan.
Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Biochem Biophys Rep. 2015 Jun 24;2:166-171. doi: 10.1016/j.bbrep.2015.06.005. eCollection 2015 Jul.
Atenolol, a β1-adrenergic receptor blocker, is administered orally and its intestinal absorption has recently been indicated to be mediated by carrier protein and reduced markedly by ingestion of some fruit juices, such as apple and orange juices. This could be postulated to be a problem arising from the interaction of some components of fruit juices with atenolol at a transporter involved in its intestinal uptake, but the responsible transporter and its interacting components have not been identified yet. In an attempt to examine that possibility, we could successfully find that human organic cation transporter 1 (OCT1/SLC22A1), which is suggested to be expressed at the brush border membrane of enterocytes, is highly capable of transporting atenolol. In this attempt, OCT1 was stably expressed in Madin-Darby canine kidney II cells and the specific uptake of atenolol by the transporter was found to be saturable, conforming to the Michaelis-Menten kinetics with the maximum transport rate () of 4.00 nmol/min/mg protein and the Michaelis constant () of 3.08 mM. Furthermore, the OCT1-specific uptake was found to be inhibited by various flavonoids, including those contained in fruit juices that have been suggested to interfere with intestinal atenolol absorption. Particularly, phloretin and quercetin, which are major components of apple juice, were potent in inhibiting OCT1-mediated atenolol transport with the inhibition constants of 38.0 and 48.0 µM, respectively. It is also notable that the inhibition by these flavonoids was of the noncompetitive type. These results indicate that OCT1 is an atenolol transporter that may be involved in intestinal atenolol uptake and sensitive to fruit juices, although its physiological and clinical relevance remains to be further examined.
阿替洛尔是一种β1 - 肾上腺素能受体阻滞剂,口服给药,最近研究表明其肠道吸收由载体蛋白介导,且某些果汁(如苹果汁和橙汁)的摄入会显著降低其吸收。这可能是由于果汁中的某些成分与阿替洛尔在其肠道摄取所涉及的转运体上相互作用而产生的问题,但负责的转运体及其相互作用成分尚未确定。为了研究这种可能性,我们成功发现人有机阳离子转运体1(OCT1/SLC22A1),该转运体被认为在肠细胞刷状缘膜上表达,具有高效转运阿替洛尔的能力。在本研究中,OCT1在Madin - Darby犬肾II细胞中稳定表达,发现该转运体对阿替洛尔的特异性摄取具有饱和性,符合米氏动力学,最大转运速率(Vmax)为4.00 nmol/min/mg蛋白,米氏常数(Km)为3.08 mM。此外,发现OCT1特异性摄取受到多种黄酮类化合物的抑制,包括那些被认为会干扰肠道阿替洛尔吸收的果汁中所含的黄酮类化合物。特别是,苹果汁中的主要成分根皮素和槲皮素对OCT1介导的阿替洛尔转运具有强效抑制作用,抑制常数分别为38.0和48.0 μM。同样值得注意的是,这些黄酮类化合物的抑制作用属于非竞争性类型。这些结果表明,OCT1是一种可能参与肠道阿替洛尔摄取且对果汁敏感的阿替洛尔转运体,尽管其生理和临床相关性仍有待进一步研究。